Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults | Zendy

Jasper van der Lugt | Zendy; R. S. Autar | Zendy; Sasiwimol Ubolyam | Zendy; E. F. Garcia | Zendy; Jongkol Sankote | Zendy; A. Avihingson | Zendy; T. Chuenyam | Zendy; David A. Cooper | Zendy; J Lange | Zendy; Praphan Phanuphak | Zendy; Ferdinand W.N.M. Wit | Zendy; Kiat Ruxrungtham | Zendy; Dylan Burger | Zendy

Open Access

Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults

Author(s) -

Jasper van der Lugt,

R. S. Autar,

Sasiwimol Ubolyam,

E. F. Garcia,

Jongkol Sankote,

A. Avihingson,

T. Chuenyam,

David A. Cooper,

J Lange,

Praphan Phanuphak,

Ferdinand W.N.M. Wit,

Kiat Ruxrungtham,

Dylan Burger

Publication year - 2008

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkn050

Subject(s) - saquinavir , lopinavir , ritonavir , pharmacokinetics , protease inhibitor (pharmacology) , lopinavir/ritonavir , regimen , medicine , pharmacology , virology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy

To study the pharmacokinetics and short-term efficacy of low and standard dose lopinavir/ritonavir and saquinavir combinations in Thai, human immunodeficiency virus (HIV)-infected, treatment-naive patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research